Hélène Bricout
Biographic Data
| ID | 7749232 |
|---|---|
| NAME | Hélène Bricout |
| GIVEN NAMES | Hélène |
| FAMILY NAME | Bricout |
| SIGNATURE | BRICOUT H |
| AFFILIATIONS | Sanofi (France) |
| ORCID | 0000-0002-5439-8064 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Public health and economic benefits of seasonal influenza vaccination in risk groups in France, Italy, Spain and the UK
Older adults represent most vaccine-preventable influenza cases and deaths, followed by individuals with chronic conditions. Health authorities should prioritise vaccinating these populations for maximum public health and economic benefits
Epidemiology of invasive meningococcal disease and sequelae in the United Kingdom during the period 2008 to 2017 – a secondary database analysis
The study showed that, despite a relatively low incidence rate, IMD is responsible for a high CFR, namely in older age groups and by a high number of IMD sequelae. The study showed that leveraging data from existing databases can be used to complement surveillance data in truly assessing the epidemiology of IMD. Despite the availability of routine vaccination programs, IMD still poses a significant burden in the healthcare system of the UK. Optim…
Clinical and economic burden of physician-diagnosed influenza in adults during the 2017/2018 epidemic season in Spain
Season 2017/2018 was associated with a considerable burden of influenza in Spain, which increased with age and presence of comorbidities. Individuals with comorbidities accounted for most of the costs of influenza. Results suggest that population aged 18-64 years old is generating the highest share of costs to the NHS when all healthcare costs are considered. Preventive strategies targeting subjects with comorbidities, regardless of age, should b…
National influenza surveillance systems in five European countries
This new framework can be used to compare influenza surveillance systems qualitatively between countries to allow the identification of structural differences as well as to evaluate adherence to WHO guidance. The framework may be adapted for other infectious respiratory diseases
No prominent works on this page.
Epidemiology of invasive meningococcal disease and sequelae in the United Kingdom during the period 2008 to 2017 – a secondary database analysis
The study showed that, despite a relatively low incidence rate, IMD is responsible for a high CFR, namely in older age groups and by a high number of IMD sequelae. The study showed that leveraging data from existing databases can be used to complement surveillance data in truly assessing the epidemiology of IMD. Despite the availability of routine vaccination programs, IMD still poses a significant burden in the healthcare system of the UK. Optim…
Clinical and economic burden of physician-diagnosed influenza in adults during the 2017/2018 epidemic season in Spain
Season 2017/2018 was associated with a considerable burden of influenza in Spain, which increased with age and presence of comorbidities. Individuals with comorbidities accounted for most of the costs of influenza. Results suggest that population aged 18-64 years old is generating the highest share of costs to the NHS when all healthcare costs are considered. Preventive strategies targeting subjects with comorbidities, regardless of age, should b…
National influenza surveillance systems in five European countries
This new framework can be used to compare influenza surveillance systems qualitatively between countries to allow the identification of structural differences as well as to evaluate adherence to WHO guidance. The framework may be adapted for other infectious respiratory diseases
Public health and economic benefits of seasonal influenza vaccination in risk groups in France, Italy, Spain and the UK
Older adults represent most vaccine-preventable influenza cases and deaths, followed by individuals with chronic conditions. Health authorities should prioritise vaccinating these populations for maximum public health and economic benefits
Biostatistics (4 works) · Epidemiology (4 works) · Medicine (4 works) · Public health (4 works) · Environmental health (3 works) · Influenza Virus Research Studies (3 works) · Pediatrics (3 works) · COVID-19 epidemiological studies (2 works) · Demography (2 works) · Demography (2 works)